HEALTH● LOW2h ago · Oct 5, 2026, 7:42 PM
Genmab, AbbVie data boosts Epkinly as first-line B-cell lymphoma treatment
Seeking Alpha Tech · global
Data from Genmab and AbbVie has enhanced the standing of Epkinly as a potential first-line treatment for B-cell lymphoma. This development indicates progress in cancer therapy options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoTrump says Russia plague reports concerning: Microbes ‘stronger and smarter’The HillHEALTHBREAKING1h agoNew York declares statewide disaster emergency as measles cases riseFrance 24 [en]HEALTH1h agoMexico and the US FDA offer conflicting accounts of last summer’s cyclospora outbreakMexico News DailyHEALTH1h agoPennsylvania measles cases pass 1K mark amid outbreakThe Hill